조영제 인젝터 시장 보고서 : 제품 유형, 인젝터 유형, 용도, 최종 사용자, 지역별(2024-2032년)

The global contrast media injectors market size reached US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.7 Billion by 2032, exhibiting a growth rate (CAGR) of 5.1% during 2024-2032. The increasing prevalence of chronic diseases, the rising demand for minimally invasive (MI) procedures, and the growing number of diagnostic imaging procedures are some of the key factors driving the market.

Contrast media injectors are essential devices used in medical imaging to enhance the visibility of blood vessels, organs, and tissues during diagnostic procedures. They consist of a syringe or reservoir for the contrast media, an injector system, and a control console. They are employed by radiologists and technicians to deliver contrast agents with precision and uniformity. By controlling the rate and volume of injection, they ensure optimal distribution of contrast media, resulting in clearer and more accurate images. This improves the diagnostic quality and helps in identifying abnormalities or diseases. Contrast media injectors help to enhance image clarity, reduce the need for rescans, and improve patient safety due to controlled dosage administration. Compared to manual injections, contrast media injectors offer consistent injection rates and reduce the risk of human error. Currently, the commonly available product variants include power injectors, dual-head injectors, and syringeless injectors.

Contrast Media Injectors Market Trends:

The global contrast media injectors market is primarily fueled by the increasing prevalence of chronic diseases and the rising demand for minimally invasive (MI) procedures. This is further bolstered by the growing number of diagnostic imaging procedures. Additionally, the development of technologically advanced contrast media injectors and the escalating product adoption in emerging economies are expected to drive the market growth. In line with this, key market players are introducing new and innovative products, including smart injectors, dual-head injectors, and integrated imaging systems, to increase their product portfolio, which is providing a considerable thrust to the market growth. Moreover, the increasing geriatric population, the burgeoning healthcare expenditure, and the growing demand for efficient and effective diagnostic procedures are creating a positive outlook for the market. Apart from this, the availability of favorable reimbursement policies and the escalating adoption of contrast media injectors in veterinary medicine are favoring the market growth. Furthermore, the surging focus on early disease diagnosis and treatment and rapid advancements in imaging technologies are boosting the market growth. Other factors, such as the escalating number of regulatory approvals of contrast agents and the rapid growth in the healthcare industry, are propelling the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global contrast media injectors market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product type, injectors type, application and end user.

Product Type Insights:

Consumables

Syringes

Tubes

Others

Injector Systems

CT Injectors

MRI Injectors

Angiography Injectors

Accessories

The report has provided a detailed breakup and analysis of the global contrast media injectors market based on the product type. This includes consumables (syringes, tubes, others) and injector systems (CT injectors, MRI injectors, angiography injectors, and accessories). According to the report, the consumables segment accounted for the largest market share.

Injectors Type Insights:

Single-head Injectors

Dual-head Injectors

Syringeless Injectors

The report has provided a detailed breakup and analysis of the global contrast media injectors market based on the injectors type. This includes single-head injectors, dual-head injectors, and syringeless injectors. According to the report, the single-head injectors segment accounted for the largest market share.

Application Insights:

Radiology

Interventional Cardiology

Interventional Radiology

The report has provided a detailed breakup and analysis of the global contrast media injectors market based on the application. This includes radiology, interventional cardiology, and interventional radiology. According to the report, the radiology segment accounted for the largest market share.

End User Insights:

Hospitals

Ambulatory Surgery Centers

Diagnostics Imaging Centers

The report has provided a detailed breakup and analysis of the global contrast media injectors market based on the end user. This includes hospitals, ambulatory surgery centers, and diagnostics imaging centers. According to the report, the hospitals segment accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. As per the report, North America was the largest market for contrast media injectors. Some of the factors driving the North America contrast media injectors market include the burgeoning healthcare expenditure, growing demand for efficient and effective diagnostic procedures, and escalating number of regulatory approvals.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global contrast media injectors market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include APOLLO RT Co. Ltd., Bayer AG, Bracco Imaging S.p.A., General Electric Company, Guerbet, Medtron AG, Nemoto Kyorindo Co. Ltd., Shenzhen Anke High-tech Co. Ltd., Shenzhen Seacrown Electromechanical Co. Ltd., Sino Medical-Device Technology Co. Ltd. and ulrich GmbH & Co. KG. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

• 1. What was the size of the global contrast media injectors market in 2023?
• 2. What is the expected growth rate of the global contrast media injectors market during 2024-2032?
• 3. What has been the impact of COVID-19 on the global contrast media injectors market?
• 4. What are the key factors driving the global contrast media injectors market?
• 5. What is the breakup of the global contrast media injectors market based on the product type?
• 6. What is the breakup of the global contrast media injectors market based on the injectors type?
• 7. What is the breakup of the global contrast media injectors market based on the application?
• 8. What is the breakup of the global contrast media injectors market based on the end user?
• 9. What are the key regions in the global contrast media injectors market?
• 10. Who are the key players/companies in the global contrast media injectors market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Contrast Media Injectors Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product Type

• 6.1 Consumables
  • 6.1.1 Market Trends
  • 6.1.2 Key Segments
    • 6.1.2.1 Syringes
    • 6.1.2.2 Tubes
    • 6.1.2.3 Others
  • 6.1.3 Market Forecast
• 6.2 Injector Systems
  • 6.2.1 Market Trends
  • 6.2.2 Key Segments
    • 6.2.2.1 CT Injectors
    • 6.2.2.2 MRI Injectors
    • 6.2.2.3 Angiography Injectors
    • 6.2.2.4 Accessories
  • 6.2.3 Market Forecast

7 Market Breakup by Injectors Type

• 7.1 Single-head Injectors
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Dual-head Injectors
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Syringeless Injectors
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Application

• 8.1 Radiology
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Interventional Cardiology
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Interventional Radiology
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by End User

• 9.1 Hospitals
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Ambulatory Surgery Centers
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Diagnostics Imaging Centers
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 APOLLO RT Co. Ltd.
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
  • 15.3.2 Bayer AG
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
    • 15.3.2.3 Financials
    • 15.3.2.4 SWOT Analysis
  • 15.3.3 Bracco Imaging S.p.A.
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
  • 15.3.4 General Electric Company
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
    • 15.3.4.3 Financials
    • 15.3.4.4 SWOT Analysis
  • 15.3.5 Guerbet
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
    • 15.3.5.3 Financials
    • 15.3.5.4 SWOT Analysis
  • 15.3.6 Medtron AG
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
  • 15.3.7 Nemoto Kyorindo Co. Ltd.
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
  • 15.3.8 Shenzhen Anke High-tech Co. Ltd.
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
  • 15.3.9 Shenzhen Seacrown Electromechanical Co. Ltd.
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
  • 15.3.10 Sino Medical-Device Technology Co. Ltd.
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
  • 15.3.11 ulrich GmbH & Co. KG
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio